Serum Phosphate Is Associated With Fracture Risk: The Rotterdam Study and MrOS

被引:47
作者
Campos-Obando, Natalia [1 ]
Koek, W. Nadia H. [1 ]
Hooker, Elizabeth R. [2 ]
van der Eerden, Bram C. J. [1 ]
Pols, Huibert A. [1 ,3 ]
Hofman, Albert [3 ]
van Leeuwen, Johannes P. T. M. [1 ]
Uitterlinden, Andre G. [1 ,3 ]
Nielson, Carrie M. [2 ,4 ]
Zillikens, M. Carola [1 ,3 ]
机构
[1] Erasmus MC, Dept Internal Med, POB 2040, NL-3000 CA Rotterdam, Netherlands
[2] Oregon Hlth & Sci Univ, Bone & Mineral Unit, Portland, OR 97201 USA
[3] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands
[4] Oregon Hlth & Sci Univ, Sch Publ Hlth, Portland, OR 97201 USA
基金
美国国家卫生研究院;
关键词
PHOSPHATE LEVELS; FRACTURES; BMD; CALCIUM; 25-HYDROXYVITAMIN D; BONE-MINERAL DENSITY; GROWTH-FACTOR; 23; OSTEOPOROTIC FRACTURES; OLDER MEN; HIP FRACTURE; VASCULAR CALCIFICATION; 25-HYDROXYVITAMIN D; PHOSPHORUS; HEALTH; FGF23;
D O I
10.1002/jbmr.3094
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Extreme phosphate levels (P) have been associated with mineralization defects and increased fracture risk. Whether P within normal range is related to bone health in the general population is not well understood. To investigate the association of P with bone mineral density (BMD) and fracture risk, we assessed two population-based cohorts: the Dutch Rotterdam Study (RS-I, RS-II, RS-III; n = 6791) and the US Osteoporotic Fractures in Men (MrOS; n = 5425) study. The relationship of P with lumbar spine (LS) and femoral neck (FN) BMD was tested in all cohorts via linear models; fracture risk was tested in RS-I, RS-II, and MrOS through Cox models, after follow-up of 8.6, 6.6, and 10.9 years, respectively. Adjustments were made for age, body mass index, smoking, serum levels of calcium, potassium, 25-hydroxyvitamin D, estimated glomerular filtration rate (eGFR), FN-BMD, prevalent diabetes, and cardiovascular disease. Additional adjustments were made for phosphate intake, parathyroid hormone, and fibroblast growth factor 23 levels in MrOS. We further stratified by eGFR. Results were pooled through study-level metaanalyses. Hazard ratios (HR) and betas (b) (from meta-analyses) are expressed per 1mg/dL P increase. P was positively associated with fracture risk in men and women from RS, and findings were replicated in MrOS (pooled HR all [95% CI]: 1.47 [1.31-1.65]). P was associated with fracture risk in subjects without chronic kidney disease (CKD): all (1.44 [1.26-1.63]) and in men with CKD (1.93 [1.42-2.62]). P was inversely related to LS-BMD in men (b: -0.06 [-0.11 to -0.02]) and not to FN-BMD in either sex. In summary, serum P was positively related to fracture risk independently from BMD and phosphate intake after adjustments for potential confounders. P and LS-BMD werenegatively related in men. Our findings suggest that increased P levels even within normal range might be deleterious for bone health in the normal population. (C) 2017 American Society for Bone and Mineral Research.
引用
收藏
页码:1182 / 1193
页数:12
相关论文
共 70 条
[31]   Fibroblast Growth Factor 23, Bone Mineral Density, and Risk of Hip Fracture Among Older Adults: The Cardiovascular Health Study [J].
Jovanovich, Anna ;
Buzkova, Petra ;
Chonchol, Michel ;
Robbins, John ;
Fink, Howard A. ;
de Boer, Ian H. ;
Kestenbaum, Bryan ;
Katz, Ronit ;
Carbone, Laura ;
Lee, Jennifer ;
Laughlin, Gail A. ;
Mukamal, Kenneth J. ;
Fried, Linda F. ;
Shlipak, Michael G. ;
Ix, Joachim H. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2013, 98 (08) :3323-3331
[32]   A reference standard for the description of osteoporosis [J].
Kanis, John A. ;
McCloskey, Eugene V. ;
Johansson, Helena ;
Oden, Anders ;
Melton, L. Joseph, III ;
Khaltaev, Nikolai .
BONE, 2008, 42 (03) :467-475
[33]   Assessment of one published review on health risks associated with phosphate additives in food [J].
Kass, Georges ;
Smeraldi, Camilla ;
Zancanaro, Gabriele .
EFSA JOURNAL, 2013, 11 (11)
[34]  
Koeppen BM, 2010, BERNE LEVY PHYSL, P557
[35]   Osteopontin deficiency suppresses high phosphate load-induced bone loss via specific modulation of osteoclasts [J].
Koyama, Yuki ;
Rittling, Susan R. ;
Tsuji, Kunikazu ;
Hino, Kazunori ;
Salincarnboriboon, Ruchanee ;
Yano, Tetsu ;
Taketani, Yuji ;
Nifuji, Akira ;
Denhardt, David T. ;
Noda, Masaki .
ENDOCRINOLOGY, 2006, 147 (06) :3040-3049
[36]   A New Equation to Estimate Glomerular Filtration Rate [J].
Levey, Andrew S. ;
Stevens, Lesley A. ;
Schmid, Christopher H. ;
Zhang, Yaping ;
Castro, Alejandro F., III ;
Feldman, Harold I. ;
Kusek, John W. ;
Eggers, Paul ;
Van Lente, Frederick ;
Greene, Tom ;
Coresh, Josef .
ANNALS OF INTERNAL MEDICINE, 2009, 150 (09) :604-612
[37]   A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation [J].
Levey, AS ;
Bosch, JP ;
Lewis, JB ;
Greene, T ;
Rogers, N ;
Roth, D .
ANNALS OF INTERNAL MEDICINE, 1999, 130 (06) :461-+
[38]   Cognitive-behavioural interventions for children who have been sexually abused [J].
Macdonald, Geraldine ;
Higgins, Julian P. T. ;
Ramchandani, Paul ;
Valentine, Jeffrey C. ;
Bronger, Latricia P. ;
Klein, Paul ;
O'Daniel, Roland ;
Pickering, Mark ;
Rademaker, Ben ;
Richardson, George ;
Taylor, Matthew .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2012, (05)
[39]   REGULATION AND FUNCTION OF THE FGF23/KLOTHO ENDOCRINE PATHWAYS [J].
Martin, Aline ;
David, Valentin ;
Quarles, L. Darryl .
PHYSIOLOGICAL REVIEWS, 2012, 92 (01) :131-155
[40]   A Novel Recessive Mutation of Fibroblast Growth Factor-23 in Tumoral Calcinosis [J].
Masi, L. ;
Gozzini, A. ;
Franchi, A. ;
Campanacci, D. ;
Amedei, A. ;
Falchetti, A. ;
Franceschelli, F. ;
Marcucci, G. ;
Tanini, A. ;
Capanna, R. ;
Brandi, M. L. .
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 2009, 91A (05) :1190-1198